{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:26:30Z","timestamp":1764246390996,"version":"3.46.0"},"reference-count":82,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunological Medicine"],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.1080\/25785826.2025.2515333","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:36:12Z","timestamp":1750739772000},"page":"295-306","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Current experience with manual push subcutaneous immunoglobulin (SCIg) in patients with immune deficiencies"],"prefix":"10.1080","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2885-1299","authenticated-orcid":false,"given":"Alex","family":"Richter","sequence":"first","affiliation":[{"name":"School of Infection, Inflammation and Immunology, University of Birmingham","place":["Birmingham, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.04.049"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810063191403"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb01874.x"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902856824"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-102631"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.14.67"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2018.1546692"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12694"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S31136"},{"issue":"12","key":"e_1_3_3_11_1","first-page":"768","article-title":"Calculating the dose of subcutaneous immunoglobulin for primary immunodeficiency disease in patients switched from intravenous to sub\u00adcutaneous immunoglobulin without the use of a dose-adjustment coefficient","volume":"38","author":"Fadeyi M","year":"2013","unstructured":"Fadeyi M, Tran T. Calculating the dose of subcutaneous immunoglobulin for primary immunodeficiency disease in patients switched from intravenous to sub\u00adcutaneous immunoglobulin without the use of a dose-adjustment coefficient. P T. 2013;38(12):768\u2013770.","journal-title":"P T"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2013.37760"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0243-z"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.08.033"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-1-55"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.04027.x"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200721020-00005"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90147-h"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32834c22da"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-006-9021-7"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1006678312925"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2008.06.006"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-006-9002-x"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783x-15-6-238"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.06.053"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-006-9031-5"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.1995.21050917.x"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13554-014-0018-0"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15375"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab072"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000864"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04983-5"},{"key":"e_1_3_3_33_1","unstructured":"Public Health England. Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19; 2020. Available from: https:\/\/media.rnib.org.uk\/documents\/20.12.20_Updated_Full_Guidance.pdf."},{"key":"e_1_3_3_34_1","unstructured":"European Centre for Disease Prevention and Control. Guidance on the provision of support for medically and socially vulnerable populations in EU\/EEA countries and the United Kingdom during the COVID-19 pandemic; 2020. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/guidance-medically-and-socially-vulnerable-populations-covid-19."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01158-5"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-216964"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744696"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.12.053"},{"key":"e_1_3_3_39_1","volume-title":"Presented at the 16th biennial meeting of the European Society for Immunodeficiencies","author":"Reniers A","year":"2014","unstructured":"Reniers A, Heijmans C, Rombaut R, et\u00a0al. Subcutaneous administration of Gammanorm (R) in immune-deficient patients by rapid push: report of the Belgian experience. Presented at the 16th biennial meeting of the European Society for Immunodeficiencies; 2014 Oct 29\u2013Nov 1; Prague: Czech Republic; 2014."},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-020-00431-3"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.08.013"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0507-x"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S156983"},{"issue":"10","key":"e_1_3_3_44_1","first-page":"385","article-title":"P. Experiencia con inmunoglobulina subcut\u00e1nea en inmunodeficiencias humorales","volume":"70","author":"Casas G.","year":"2012","unstructured":"Casas G. P. Experiencia con inmunoglobulina subcut\u00e1nea en inmunodeficiencias humorales. Acta Pediatr Esp. 2012;70(10):385\u2013391.","journal-title":"Acta Pediatr Esp"},{"key":"e_1_3_3_45_1","first-page":"28","article-title":"Subcutaneous immunoglobulin replacement therapy experience with intravenous preparation","volume":"17","author":"Ozdemir O.","year":"2019","unstructured":"Ozdemir O. Subcutaneous immunoglobulin replacement therapy experience with intravenous preparation. Asth Allerg Immunol. 2019;17:28\u201333.","journal-title":"Asth Allerg Immunol"},{"key":"e_1_3_3_46_1","volume-title":"Presented at UKPIN 2015 meeting. United Kingdom","author":"Jones C.","year":"2015","unstructured":"Jones C. Treatment satisfaction upon switching to flexibly-dosed SCIg in PID. Presented at UKPIN 2015 meeting. United Kingdom; 2015."},{"issue":"1","key":"e_1_3_3_47_1","first-page":"1","article-title":"Is daily subcutaneous immunoglobulin acceptable to patients undergoing immunoglobulin replacement for immune deficiency?","volume":"182","author":"Leeman L","year":"2015","unstructured":"Leeman L, Bethune C, Symons C, et\u00a0al. Is daily subcutaneous immunoglobulin acceptable to patients undergoing immunoglobulin replacement for immune deficiency? Clin Exp Immunol. 2015;182(Suppl 1):1\u201334.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_3_48_1","volume-title":"Presented at the International Primary Immunodeficiencies Congress (IPIC) 2017","author":"Richter AG","year":"2017","unstructured":"Richter AG, Knight EJ. Manual push subcutaneous immunoglobulin administration in patients with primary and secondary immunodeficiencies and autoimmune disorders: a case series of 18 patients. Presented at the International Primary Immunodeficiencies Congress (IPIC) 2017; 8 Nov 2017; Dubai, UAE; 2017."},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.05.004"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108938"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-009-9352-2"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2013.04.015"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12099"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12026"},{"issue":"2","key":"e_1_3_3_55_1","first-page":"1000148","article-title":"Subcutaneous IgG replacement therapy by push in 32 patients with primary immunodeficiency diseases in Argentine","volume":"4","author":"Bezrodnik L","year":"2014","unstructured":"Bezrodnik L, G\u00f3mez Raccio A, Regairaz L, et\u00a0al. Subcutaneous IgG replacement therapy by push in 32 patients with primary immunodeficiency diseases in Argentine. Clin Exp Pharmacol. 2014;4(2):1000148.","journal-title":"Clin Exp Pharmacol"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.67_13197"},{"key":"e_1_3_3_57_1","first-page":"25","article-title":"Subcutaneous immunoglobulin administration survey: syringe driver versus rapid push","volume":"46","author":"Stephens S","year":"2016","unstructured":"Stephens S, Out M-S, Capstick J, et\u00a0al. Subcutaneous immunoglobulin administration survey: syringe driver versus rapid push. Internal Med J. 2016;46:25.","journal-title":"Internal Med J"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2012.01201.x"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.14196\/mjiri.31.94"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.957678"},{"key":"e_1_3_3_61_1","volume-title":"PNS Annual Meeting 2020","author":"Roberts R.","year":"2020","unstructured":"Roberts R. Switching to subcutaneous immunoglobulin by manual push: a single centre experience. PNS Annual Meeting 2020; 2020."},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106240"},{"key":"e_1_3_3_63_1","unstructured":"US Department of Health and Human Services FaDA CfBEaR. Draft guidance for industry: safety efficacy and pharmacokineticstudies to support marketing of immune globulin intravenous (human) as replacement therapy for primary humoral immunodeficiency; 2005."},{"key":"e_1_3_3_64_1","unstructured":"ECfPM P. Note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use. London England: European Agency for Evaluation of Medicinal Products; 2002. Available from: http:\/\/www.emea.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500004255.pdf."},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.023"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-022-00726-7"},{"key":"e_1_3_3_67_1","volume-title":"Presented at the 16th ESID Biennial Meeting","author":"Sediva A","year":"2014","unstructured":"Sediva A, Kr\u00e1l\u00ed\u010dkov\u00e1 P, J\u00edlek D, et\u00a0al. CHINSTRAP CzecH Hizentra non-Interventional STudy with RApid Push. Patient\u2019s satisfaction and compliance with a therapy with 20% subcutaneous immunoglobulin. Presented at the 16th ESID Biennial Meeting. Prague Czech Republic, 30; 2014."},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.21203\/rs.2.16903\/v1"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00912-5"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00876-6"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01299"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008742"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.47.3.674"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30378-2"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25409"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07640-3"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00040"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01509-4"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190020938212"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-0969-0"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.06.047"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13665"},{"issue":"6","key":"e_1_3_3_83_1","first-page":"S98","article-title":"Differentiating characteristics and evaluating intravenous and subcutaneous immunoglobulin","volume":"25","author":"Ness S.","year":"2019","unstructured":"Ness S. Differentiating characteristics and evaluating intravenous and subcutaneous immunoglobulin. Am J Manag Care. 2019;25(6 Suppl):S98\u2013S104.","journal-title":"Am J Manag Care"}],"container-title":["Immunological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/25785826.2025.2515333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:22:37Z","timestamp":1764246157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/25785826.2025.2515333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10,2]]}},"alternative-id":["10.1080\/25785826.2025.2515333"],"URL":"https:\/\/doi.org\/10.1080\/25785826.2025.2515333","relation":{},"ISSN":["2578-5826"],"issn-type":[{"type":"electronic","value":"2578-5826"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=timm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=timm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}